In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead explores the remarkable journey of AstraZeneca, from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decline, and ultimately its reinvention as a science-driven leader in oncology, cardiometabolic health, and global public health.
Discover how bold leadership, high-risk bets, and groundbreaking discoveries like Tagrisso, Enhertu, and Farxiga transformed AstraZeneca into one of today’s most innovative pharmaceutical giants.
🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#AstraZeneca #BiotechUnleashed #PetriDishPerspectives #BiotechPodcast #PharmaInnovation #Oncology #CardiometabolicHealth #PrecisionMedicine #DrugDiscovery #HealthcareLeadership
© 2025 Petri Dish Perspectives LLC. All rights reserved.
